Clinical Trial Update: Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety, immunogenicity, and reactogenicity of the Mencevax ACW135 meningococcal vaccine for meningococcal meningitis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Mencevax ACW135 Vaccine

Snippet

Sponsor: Armauer Hansen Research Institute, Ethiopia | Conditions: Meningococcal Meningitis | Phase 2 | Status: COMPLETED